Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c3477f7f2cfee0da190ccf98249e0a1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-22023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-22051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-22022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f1b77962123a31c1a95fe7696ede302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7d8199f958fad654bdbbcffb2a095a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4761d6509204e596de65e2c41b24b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1041691df4618b8c37328b0cc68a6a59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78680c3b52e8f2d8df94fb04e8427a8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e00283e07378d829778b6910cbd09db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf7a47a68bcb964f5b366fb8b7c0529 |
publicationDate |
2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10975359-B2 |
titleOfInvention |
Retargeting of viruses or VLPs |
abstract |
The present invention relates to a method of producing a polyomavirus or polyomavirus-derived virus-like particle (vlp) carrying on its surface at least one targeting molecule that binds to a cell of interest. Furthermore, the present invention relates to a composition comprising such a polyomavirus or polyomavirus-derived vlp and to the use of the polyomavirus or polyomavirus-derived vlp of the invention or the composition of the invention for use as a medicament. The present invention further relates to a kit comprising the polyomavirus or polyomavirus-derived vlp or the composition of the invention. |
priorityDate |
2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |